Small molecule inhibitor of the Ral small G proteins for triple-negative breast cancer (TNBC)
TS-075232 — Problem
Breast cancer (BC) is the most commonly diagnosed malignancy and the second leading cause of cancer-related death among women in the United States. Within its subtypes, triple-negative breast cancer (TNBC) carries the highest mortality, driven in large part by a lack of effective targeted t…
- College: College of Medicine (COM)
- Inventors: Sizemore, Steven; Lindert, Steffen
- Licensing Officer: Bhatti, Hamid
